Orencia Related Clinical Trials
Efficacy, Pharmacokinetics, Safety and Immunogenicity Study of Abatacept Administered Subcutaneously to Treat Rheumatoid Arthritis in Japan [Recruiting]
Pharmacokinetic Study to Compare the Blood Levels of Abatacept Manufactured at Lonza Biologics to the Blood Levels of Abatacept Manufactured at the Devens, MA Facility of Bristol-Myers Squibb [Not yet recruiting]
Effect on Orencia (Abatacept) on the Apoptosis of T Cells, B Cells and APC Cells in Rheumatoid Arthritis [Not yet recruiting]
Efficacy and Safety Study of Abatacept to Treat Lupus Nephritis [Not yet recruiting]
Abatacept in the Treatment of Uveitis [Recruiting]
Efficacy and Safety of Abatacept Subcutaneous (SC) in Combination With Methotrexate in Adults With Very Early Rheumatoid Arthritis (RA) [Recruiting]
TOward the Lowest Effective DOse of Abatacept or Tocilizumab [Recruiting]
Abatacept for Treating Adults With Giant Cell Arteritis and Takayasu's Arteritis [Recruiting]
Vaccination Study of Abatacept (BMS-188667) for Normal Healthy Volunteers [Completed]
Study to Evaluate The Safety and Efficacy of Abatacept in Subjects With Chronic Urticaria Who Have Had an Inadequate Response to Anti-histamine Therapy [Recruiting]
Abatacept and Cyclophosphamide Combination Therapy for Lupus Nephritis [Recruiting]
Abatacept Post-marketing Clinical Study in Japan [Not yet recruiting]
Safety and Tolerability Trial of Abatacept-based Immunosuppression for Prevention of Acute Graft Versus Host Disease (aGVHD) During Transplant [Recruiting]
Abatacept Versus Adalimumab Head-to-Head [Recruiting]
Benefits of Injectable Abatacept Using Magnetic Resonance Imaging (MRI) in Rheumatoid Arthritis (RA) Patients [Recruiting]
Korean Post-marketing Surveillance for Orencia® [Recruiting]
Abatacept as GVHD Prophylaxis Phase 2 [Not yet recruiting]
CTLA4-Ig (Abatacept)for Prevention of Abnormal Glucose Tolerance and Diabetes in Relatives At -Risk for Type 1 [Not yet recruiting]
A Rheumatoid Arthritis Study to Assess Early Response to Abatacept+MTX as Defined by Improvement of Synovitis Measures by Power Doppler Ultrasonography [Recruiting]
A Cooperative Clinical Study of Abatacept in Multiple Sclerosis [Recruiting]
A Pilot Study of the Safety and Efficacy of Abatacept Injections in the Treatment of Behcet's Syndrome [Recruiting]
Abatacept Treatment in Polymyositis and Dermatomyositis [Recruiting]
Abatacept Costimulatory Blockade in the Treatment of Alopecia Totalis/Universalis [Not yet recruiting]
Study on the Safety of Abatacept in Relapsing Polychondritis [Recruiting]
Costimulation Inhibition in Asthma [Recruiting]
A Study of Abatacept in Patients With Active Ulcerative Colitis [Recruiting]
Ultrasound Scores as Indication of Response to Subcutaneous Abatacept in Subjects With Rheumatoid Arthritis [Recruiting]
Study of Abatacept (BMS-188667) in Subjects With Active Rheumatoid Arthritis on Background Non-Biologic DMARDS (Disease Modifying Antirheumatic Drugs) Who Have an Inadequate Response to Anti-TNF Therapy [Active, not recruiting]
Monitoring Epstein-Barr Virus (EBV) Load in Rheumatoid Arthritis Patients Treated With New Immunosuppressive Drugs [Recruiting]
Efficacy and Safety Study of Abatacept to Treat Lupus Nephritis [Recruiting]
Pilot Open Label Clinical Trial With Abatacept in Ankylosing Spondylitis [Recruiting]
Study to Assess Steady-State Trough Concentrations, Safety, and Immunogenicity of Abatacept After SC Administration to Subjects With RA [Active, not recruiting]
Impact of Subcutaneous Abatacept in Rheumatoid Arthritis Assessing Inhibition of Structural Damage [Recruiting]
A Phase III Study of Abatacept in Japanese Subjects With Rheumatoid Arthritis [Recruiting]
Phase IIIB Switching From Intravenous to Subcutaneous Study [Recruiting]
Safety Study of Abatacept to Treat Refractory Sarcoidosis [Recruiting]
Phase I/II Multiple-Dose LEA29Y vs CTLAG4Ig vs Placebo in Rheumatoid Arthritis [Completed]
Phase III Study of BMS-188667 (CTLA4Ig) in Patients With Rheumatoid Arthritis Who Are Currently Failing Anti-TNF Therapy or Who Have Failed Anti-TNF Therapy in the Past. [Completed]
Abatacept in Treating Adults With Mild Relapsing Wegener's Granulomatosis [Recruiting]
BMS-188667 in Children and Adolescents With Juvenile Rheumatoid Arthritis [Completed]
A Study of Abatacept in Japanese Patients With Active Rheumatoid Arthritis While Receiving Methotrexate [Recruiting]
A Phase IIIb Study of BMS-188667 in Subjects With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate [Recruiting]
The Study of Abatacept in Combination With Etanercept [Completed]
A Study of Abatacept in Patients With Active Crohn's Disease [Recruiting]
Abatacept in ANCA Associated Vasculitis [Recruiting]
Abatacept and Infliximab in Combination With Methotrexate in Subjects With Rheumatoid Arthritis [Completed]
An Exploratory Study of Changes in Synovial Immune Responses Following BMS-188667 Therapy in Subjects With Active Rheumatoid Arthritis on Background DMARDs Who Have Failed Anti-TNF Therapy [Completed]
Safety and Efficacy of Abatacept Versus Placebo in Subjects With Psoriatic Arthritis [Recruiting]
A Study to Evaluate the Safety and Efficacy of Abatacept in Patients With Diffuse Systemic Sclerosis (Scleroderma) [Recruiting]
An Observational Registry of Abatacept in Patients With Juvenile Idiopathic Arthritis [Not yet recruiting]
Phase III Study in China - Tolerance [Recruiting]
SWITCH Clinical Trial for Patients With Rheumatoid Arthritis Who Have Failed an Initial TNF-blocking Drug. [Not yet recruiting]
A Phase III Study of Abatacept in Patients With Rheumatoid Arthritis, With an Inadequate Response to Methotrexate [Recruiting]
Study of Abatacept Versus Placebo to Assess the Prevention of Rheumatoid Arthritis (RA) in Adult Patients [Active, not recruiting]
Remission in Early Rheumatoid Arthritis [Active, not recruiting]
Phase II Randomized, Double-Blind, Placebo-Controlled Study of BMS-188667 (CTLA4Ig) in Patients With Psoriasis Vulgaris [Completed]
Abatacept in the Treatment and Prevention of Active Systemic Lupus Erythematosus (SLE) Flares in Combination With Prednisone [Completed]
Comparability DE vs CD-CHO1 [Completed]
Phase I Study of BMS-188667 (CTLA4Ig) in Patients With Psoriasis Vulgaris [Completed]
A Study to Assess the Pharmacokinetics, Immunogenicity and Safety of Escalating Doses of BMS-188667 Given as a Single Intravenous Infusion to Patients With Psoriasis Vulgaris [Completed]
Intravenous CTLA4-lg Treatment in Recent Onset Type 1 Diabetes Mellitus [Recruiting]
A Phase III Study of BMS-188667 in Subjects With Active Rheumatoid Arthritis [Completed]
A Phase III Study of BMS-188667 in Patients With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate [Completed]
Phase IIIB Subcutaneous Missed Dose Study [Recruiting]
LEA29Y (Belatacept) Emory Edmonton Protocol [Recruiting]
A Study to Evaluate the Preliminary Efficacy Pharmacokinetics and Immunogenicity of BMS-188667 Administered to Subjects With Relapsing-Remitting Multiple Sclerosis [Terminated]
CTLA4IG With Methotrexate- Phase IIB - Long Term [Completed]
Rotation or Change of Biotherapy After First Anti-TNF Treatment Failure for Rheumatoid Arthritis [Recruiting]
Belatacept Post Depletional Repopulation to Facilitate Tolerance [Recruiting]
A Belatacept Compassionate Use Study for Patients With a Kidney Transplant [Available]
Belatacept to Prevent Organ Rejection in Kidney Transplant Patients [Recruiting]
Study Comparing the Safety and Efficacy of BMS-224818 to Cyclosporine, in Patients Receiving a Kidney Transplant, When Used in Combination With CellCept, Simulect, and Corticosteroids. [Completed]
A Study of BMS-224818 (Belatacept) in Patients Who Have Undergone a Kidney Transplant and Are Currently on Stable Cyclosporine or Tacrolimus Regimen With or Without Corticosteroids [Recruiting]
Study of Belatacept in Subjects Who Are Undergoing a Renal Transplant [Active, not recruiting]
Belatacept Evaluation of Nephroprotection and Efficacy as First-Line Immunosuppression (BENEFIT) [Active, not recruiting]
Study of Belatacept (BMS-224818) With a Steroid-Free Regimen in Subjects Undergoing Kidney Transplantation [Recruiting]
Calcineurin Inhibitor-free, Steroid-free Immunosuppressive Regimen in Simultaneous Islet-Kidney Transplantation for Uremic Type 1 Diabetic Patients [Recruiting]
Belatacept Pharmacokinetic Trial in Renal Transplantation [Recruiting]
Belatacept in Liver Transplant Recipients [Recruiting]
|
